Abiopharma

Arcadia Biosciences (RKDA) Announces $4 Million Private Placement Priced At-The-Market Under Nasdaq Rules

INVESTOR ALERT: Securities Class Action Filed Against Erasca, Inc. – Investors Encouraged to Contact Kirby McInerney LLP

HUTCHMED Highlights Sovleplenib ESLIM-02 Phase III Data in Warm Antibody Autoimmune Hemolytic Anemia Presented at EHA 2026 Congress

NowVertical Appoints Andre Garber as Interim CEO of the Company

Nasdaq-100 Index® June 2026 Quarterly Changes

Extraordinary/ Special General Meeting:

General Announcement: The exchange offer in relation to the S$53.8m Notes due 2026

Change - Announcement of Appointment: Re-designation of Mr Oh Kwok Fon from Assistant Business Director to Assistant Finance Director

Change - Announcement of Cessation: Resignation of Finance Director

Extraordinary/ Special General Meeting: